Combination of Minimal Residual Disease By Flow Cytometry before and after Hematopoietic Stem Cell Transplantation Predicts Survival in Patients with Acute Myeloid Leukemia

被引：0
|
作者：
Nunez-Torron, Claudia [1 ]
Jimenez, Carlos [2 ]
Moro, Fernando Martin [3 ]
Marquet, Juan [4 ]
Piris-Villaespesa, Miguel [5 ]
Hernandez, Clara Lopez [6 ]
Luna, Alejandro [7 ]
Gutierrez Sr, Valentin Garcia [8 ]
Chinea, Anabelle
Jimenez, Maria Gemma Moreno [5 ]
Lopez, Javier [3 ]
Puente, Pilar Herrera [5 ]
机构：
[1] Hosp Infanta Sofia, Madrid, Spain
[2] Hosp Univ Gregorio Maranon, Madrid, Spain
[3] Hosp Univ Ramon Y Cajal, Hematol, Madrid, Spain
[4] Hosp Univ Ramon Y Cajal, Hematol Dept, Madrid, Spain
[5] Hosp Univ Ramon y Cajal Irycis, Madrid, Spain
[6] Hosp Univ Ramon Y Cajal, Madrid, Spain
[7] Hosp Univ Ramon Y Cajal, Unidad Trasplante & Terapia Celular, Madrid, Spain
[8] Hosp Univ Ramon Y Cajal IRYCIS, Dept Hematol & Hemoterapia, Madrid, Spain
来源：
BLOOD | 2024年 / 144卷
关键词：
D O I：
10.1182/blood-2024-210576
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：7445 / 7446
页数：2
相关论文
共 50 条
  • [31] MONITORING OF CHIMERISM IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION BY QUANTITATIVE ASSESSMENT: THE BEST TOOL FOR MONITORING OF MINIMAL RESIDUAL DISEASE?
    Bouvier, A.
    Thepot, S.
    Francois, S.
    Guardiola, P.
    Tanguy-Schmidt, A.
    Beucher, A.
    Genevieve, F.
    Hunault-Berger, M.
    Zandecki, M.
    Ifrah, N.
    Blanchet, O.
    HAEMATOLOGICA, 2014, 99 : 553 - 554
  • [32] Pretransplantation minimal residual disease monitoring by multiparameter flow cytometry predicts outcomes of AML patients receiving allogeneic hematopoietic stem cell transplantation
    Zhang, Yun
    Wang, Ping
    Cassady, Kaniel
    Zou, Zhongmin
    Li, Yi
    Deng, Xiaojuan
    Yang, Wuchen
    Peng, Xiangui
    Zhang, Xi
    Feng, Yimei
    TRANSPLANT IMMUNOLOGY, 2022, 72
  • [33] Value of Pretransplantation Minimal Residual Disease in Acute Myeloid Leukemia and Myeloablative Hematopoietic Cell Transplantation
    Bento, Leyre
    Kwon, Mi
    Buno, Ismael
    Martinez-Laperche, Carolina
    Anguita, Javier
    Perez-Corral, Ana M.
    Pascual, Cristina
    Balsalobre, Pascual
    Serrano, David
    Gayoso, Jorge
    Luis Diez-Martin, Jose
    BLOOD, 2012, 120 (21)
  • [34] Multidimensional flow cytometry for detection of minimal residual disease in acute myeloid leukemia
    Venditti, A
    Maurillo, L
    Buccisano, F
    Tamburini, A
    Del Poeta, G
    Del Principe, MI
    Panetta, P
    Consalvo, MI
    Mazzone, C
    Tendas, A
    Trawinska, M
    Forte, V
    Amadori, S
    LEUKEMIA & LYMPHOMA, 2003, 44 (03) : 445 - 450
  • [35] Minimal Residual Disease Monitoring by Flow Cytometry in Pediatric Acute Myeloid Leukemia
    Rubnitz, J.
    ANNALS OF HEMATOLOGY, 2013, 92 : S55 - S55
  • [36] Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation
    Hao, Yingchan
    Cheng, Yanhong
    Wu, Quan
    Zhang, Aimei
    Jiang, Xiaoxiao
    Xu, Xiucai
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1403 - 1409
  • [37] Residual Disease Detection by Flow Cytometry Predicts Risk of Relapse and Overall Survival in Patients with Acute Myeloid Leukemia Following Reduced Intensity- and Myeloablative- Allogeneic Hematopoietic Cell Transplantation
    Bradbury, Charlotte Ann
    Ward, Janice
    Vyas, Paresh
    Russell, Nigel H.
    David, Grimwade
    Hills, Robert K.
    Burnett, Alan K.
    Craddock, Charles F.
    Sylvie, Freeman
    BLOOD, 2012, 120 (21)
  • [38] Allogeneic Hematopoietic Stem Cell Transplantation Overcomes the Adverse Prognostic Impact of Minimal Residual Disease in Acute Myeloid Leukemia
    Oran, Betul
    Singleton, Timothy
    Ramirez, Pablo A.
    Shanley, Ryan
    Brunstein, Claudio
    Ustun, Celalettin
    Warlick, Erica D.
    Weisdorf, Daniel J.
    BLOOD, 2011, 118 (21) : 887 - 887
  • [39] Feasibility of monitoring for minimal residual disease by multiparameter flow cytometry in patients with acute myeloid leukemia
    Kern, W
    Danhauser-Riedl, S
    Schnittger, S
    Schoch, S
    Haferlach, T
    Hiddemann, W
    CYTOMETRY, 2001, 46 (05): : 328 - 328
  • [40] Impact of NCCN Risk Stratification and Minimal Residual Disease on Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
    Lu, Yue
    Wu, Tong
    Zhao, Yan-Li
    Cao, Xing-Yu
    Liu, De-Yan
    Zhang, Jian-Ping
    Xiong, Min
    Zhou, Jia-Rui
    Sun, Rui-Juan
    Wei, Zhi-Jie
    Wang, Hui
    Wang, Tong
    Liu, Hong-Xing
    Lu, Dao-Pei
    BLOOD, 2016, 128 (22)
12345